The gut microbiota shapes intestinal immune responses during health and disease

Immunological dysregulation is the cause of many non-infectious human diseases such as autoimmunity, allergy and cancer. The gastrointestinal tract is the primary site of interaction between the host immune system and microorganisms, both symbiotic and pathogenic. In this Review we discuss findings indicating that developmental aspects of the adaptive immune system are influenced by bacterial colonization of the gut. We also highlight the molecular pathways that mediate host–symbiont interactions that regulate proper immune function. Finally, we present recent evidence to support that disturbances in the bacterial microbiota result in dysregulation of adaptive immune cells, and this may underlie disorders such as inflammatory bowel disease. This raises the possibility that the mammalian immune system, which seems to be designed to control microorganisms, is in fact controlled by microorganisms.

[1]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[2]  N. Pace,et al.  Gastrointestinal microbiology enters the metagenomics era , 2008, Current opinion in gastroenterology.

[3]  J. Gordon,et al.  A Model of Host-Microbial Interactions in an Open Mammalian Ecosystem , 1996, Science.

[4]  D. Bessesen,et al.  Human gut microbes associated with obesity , 2007 .

[5]  J. Doré,et al.  Biodiversity of the Mucosa‐Associated Microbiota Is Stable Along the Distal Digestive Tract in Healthy Individuals and Patients With Ibd , 2005, Inflammatory bowel diseases.

[6]  Fiona Powrie,et al.  Immunology. Regulating the regulators. , 2003, Science.

[7]  R Balfour Sartor,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[8]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[9]  R. Bibiloni,et al.  VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis , 2005, The American Journal of Gastroenterology.

[10]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[11]  G. Bouma,et al.  The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.

[12]  J. Gordon,et al.  Genomic and Metabolic Studies of the Impact of Probiotics on a Model Gut Symbiont and Host , 2006, PLoS biology.

[13]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[14]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[15]  Rob Knight,et al.  Host-bacterial coevolution and the search for new drug targets. , 2008, Current opinion in chemical biology.

[16]  M. Battaglia,et al.  Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans , 2007, Nature Reviews Immunology.

[17]  H. Sprinz,et al.  The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri. , 1961, The American journal of pathology.

[18]  K. Tanaka,et al.  Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells , 2008, Clinical and experimental immunology.

[19]  J. Sirard,et al.  A Key Role of Dendritic Cells in Probiotic Functionality , 2007, PloS one.

[20]  N. Barnich,et al.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. , 2007, The Journal of clinical investigation.

[21]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[22]  D. Brassart,et al.  Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. , 2007, World journal of gastroenterology.

[23]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[24]  G. Dougan,et al.  Salmonella enterica Serovar Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota , 2007, PLoS biology.

[25]  Y. Belkaid,et al.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.

[26]  J. Gordon,et al.  Creating and Maintaining the Gastrointestinal Ecosystem: What We Know and Need To Know from Gnotobiology , 1998, Microbiology and Molecular Biology Reviews.

[27]  Wendy S. Garrett,et al.  Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.

[28]  R. Reifen,et al.  Therapeutic Potential of Two Probiotics in Inflammatory Bowel Disease as observed in the Trinitrobenzene Sulfonic Acid Model of Colitis , 2008, Diseases of the colon and rectum.

[29]  L. Glimcher Trawling for treasure: tales of T-bet , 2007, Nature Immunology.

[30]  M. Comalada,et al.  A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis , 2007, British Journal of Nutrition.

[31]  D. Hentges,et al.  Experimental Shigella Infections in Laboratory Animals I. Antagonism by Human Normal Flora Components in Gnotobiotic Mice , 1972, Infection and immunity.

[32]  E. Telemo,et al.  Impaired regulatory T cell function in germ‐free mice , 2006, European journal of immunology.

[33]  R. Summers,et al.  Effect of Antibiotics on Bacterial Flora of Rats with Intestinal Blind Loops 1 , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[34]  B. Björkstén The environmental influence on childhood asthma , 1999, Allergy.

[35]  I. Leodolter [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.

[36]  F. Shanahan,et al.  The gut flora as a forgotten organ , 2006, EMBO reports.

[37]  Shimon Sakaguchi,et al.  Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.

[38]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[39]  K. Boyd,et al.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function , 2007, Nature.

[40]  C. Elson,et al.  Commensal bacteria as targets in Crohn's disease. , 2000, Gastroenterology.

[41]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[42]  F. Powrie,et al.  Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis , 2008, Immunity.

[43]  F. Kroese,et al.  B-1 cells and their reactivity with the murine intestinal microflora. , 1996, Seminars in immunology.

[44]  A. Cerutti The regulation of IgA class switching , 2008, Nature Reviews Immunology.

[45]  M. Kronenberg,et al.  II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[46]  M. Comalada,et al.  A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis , 2007, Journal of applied microbiology.

[47]  I. Forgacs,et al.  Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. , 1996, Gut.

[48]  N. Pace,et al.  Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. , 2008, Cell host & microbe.

[49]  J. Gordon,et al.  Commensal Host-Bacterial Relationships in the Gut , 2001, Science.

[50]  Keiichiro Suzuki,et al.  Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Terhorst,et al.  Pathways of T cell Pathology in Models of Chronic Intestinal Inflammation , 2000, International reviews of immunology.

[52]  F. Powrie,et al.  Regulating the Regulators , 2003, Science.

[53]  M. Kalliomäki,et al.  Pandemic of atopic diseases--a lack of microbial exposure in early infancy? , 2002, Current drug targets. Infectious disorders.

[54]  R. Knight,et al.  The human microbiome: eliminating the biomedical/environmental dichotomy in microbial ecology. , 2007, Environmental microbiology.

[55]  G. Huffnagle,et al.  Does the microbiota regulate immune responses outside the gut? , 2004, Trends in microbiology.

[56]  H. Rath Role of Commensal Bacteria in Chronic Experimental Colitis: Lessons from the HLA-B27 Transgenic Rat , 2003, Pathobiology.

[57]  Daniel B. DiGiulio,et al.  Development of the Human Infant Intestinal Microbiota , 2007, PLoS biology.

[58]  R. D. Hatton,et al.  Generation of Antigen-Specific, Foxp3-Expressing CD4+ Regulatory T Cells by Inhibition of APC Proteosome Function1 , 2005, The Journal of Immunology.

[59]  S. Pettersson,et al.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.

[60]  J. Bienenstock,et al.  Live Lactobacillus reuteri Is Essential for the Inhibitory Effect on Tumor Necrosis Factor Alpha-Induced Interleukin-8 Expression , 2004, Infection and Immunity.

[61]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[62]  S. Mazmanian,et al.  The love–hate relationship between bacterial polysaccharides and the host immune system , 2006, Nature Reviews Immunology.

[63]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[64]  S. Targan,et al.  Defects in mucosal immunity leading to ulcerative colitis , 2005, Immunological reviews.

[65]  J. Berzofsky,et al.  Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. , 2008, Immunity.

[66]  M. Stolte,et al.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.

[67]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[68]  E. Bambirra,et al.  Intragastric infection of germfree and conventional mice with Salmonella typhimurium. , 1989, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[69]  R. Hammer,et al.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats , 1994, The Journal of experimental medicine.

[70]  R. Ducluzeau,et al.  Increase in the Population of Duodenal Immunoglobulin A Plasmocytes in Axenic Mice Associated with Different Living or Dead Bacterial Strains of Intestinal Origin , 1978, Infection and immunity.

[71]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[72]  Gérard Eberl,et al.  Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis , 2008, Nature.

[73]  L. Hooper,et al.  Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin , 2006, Science.

[74]  R. Knight,et al.  Evolution of Mammals and Their Gut Microbes , 2008, Science.

[75]  B. Wiedenmann,et al.  Escherichia coli Strain Nissle 1917 Ameliorates Experimental Colitis via Toll-Like Receptor 2- and Toll-Like Receptor 4-Dependent Pathways , 2006, Infection and Immunity.

[76]  M. Kalliomäki,et al.  Role of intestinal flora in the development of allergy , 2003, Current opinion in allergy and clinical immunology.

[77]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[78]  D. Savage,et al.  Microbial interference and colonization of the murine gastrointestinal tract by Listeria monocytogenes , 1979, Infection and immunity.

[79]  F. Obermeier,et al.  Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis , 2005, Gut.

[80]  K. McCoy,et al.  Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria , 2005, Immunology.

[81]  稲垣 宏之 Increased susceptibility to primary infection with Listeria monocytogenes in germfree mice may be due to lack of accumulation of L-selectin[+]CD44[+] T cells in sites of inflammation , 1996 .

[82]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[83]  T. Hibi,et al.  IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease , 2008, Gut.

[84]  F. Powrie,et al.  Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus , 1997, Infection and immunity.

[85]  J. Andersen,et al.  Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[86]  F. Guarner,et al.  Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. , 1994, Gut.

[87]  J. Gordon,et al.  IgA response to symbiotic bacteria as a mediator of gut homeostasis. , 2007, Cell host & microbe.

[88]  A. Macpherson,et al.  Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria , 2004, Science.

[89]  C. Jobin,et al.  Dual‐association of gnotobiotic Il‐10−/− mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis , 2007, Inflammatory bowel diseases.

[90]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[91]  L. Hooper,et al.  Bacterial contributions to mammalian gut development. , 2004, Trends in microbiology.

[92]  Masahiro Yamamoto,et al.  ATP drives lamina propria TH17 cell differentiation , 2008, Nature.

[93]  D. Relman,et al.  An ecological and evolutionary perspective on human–microbe mutualism and disease , 2007, Nature.

[94]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[95]  F. Shanahan,et al.  Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.

[96]  P. Scully,et al.  Commensal-Induced Regulatory T Cells Mediate Protection against Pathogen-Stimulated NF-κB Activation , 2008, PLoS pathogens.

[97]  M. Marinaro,et al.  Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β-Bearing Regulatory Cells1 , 2005, The Journal of Immunology.

[98]  P. Scully,et al.  Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses , 2009, Biological Psychiatry.

[99]  C. Fiocchi Mucosal immunity and inflammation , 1989 .

[100]  G. Abrams,et al.  Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice. , 1963, Laboratory investigation; a journal of technical methods and pathology.

[101]  Piet A van den Brandt,et al.  Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study , 2006, Gut.

[102]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[103]  G. Tannock Exploring the relationships between intestinal microflora and inflammatory conditions of the human bowel and spine , 2002, Antonie van Leeuwenhoek.

[104]  A. Plebani,et al.  Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. , 2007, Immunity.

[105]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[106]  D. Pomp,et al.  Complex genetics of obesity in mouse models. , 2008, Annual review of nutrition.

[107]  R. Sartor The influence of normal microbial flora on the development of chronic mucosal inflammation. , 1997, Research in immunology.

[108]  A. Macpherson,et al.  Interactions between commensal intestinal bacteria and the immune system , 2004, Nature Reviews Immunology.

[109]  R. Knight,et al.  The Human Microbiome Project , 2007, Nature.

[110]  S. Brand,et al.  Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL‐22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status , 2008, Inflammatory bowel diseases.

[111]  M. Kronenberg,et al.  Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model. , 1999, The American journal of physiology.

[112]  D. Podolsky The current future understanding of inflammatory bowel disease. , 2002, Best practice & research. Clinical gastroenterology.

[113]  K. Madsen,et al.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. , 1999, Gastroenterology.

[114]  R. Kastelein,et al.  Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine , 2008, The Journal of experimental medicine.

[115]  F. Powrie,et al.  Interleukin-23 drives innate and T cell–mediated intestinal inflammation , 2006, The Journal of experimental medicine.

[116]  S. Akira,et al.  Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells , 2007, Nature.

[117]  A. Sher,et al.  IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.

[118]  M. Kamm,et al.  Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis , 2003, Gut.

[119]  T. Mcclanahan,et al.  Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. , 2007, Gastroenterology.

[120]  R. Sartor,et al.  Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice , 2002, Inflammatory bowel diseases.